Track Elevidys. Free.
AI summary
Elevidys is a one-time AAV-based gene therapy for ambulatory patients aged 4 years and older with Duchenne muscular dystrophy who have a confirmed DMD gene mutation.
AI named Elevidys from October 2025 to February 2026.
